ROBINS CHAD M

PrivateCIK: 1780649
Location

SEATTLE, WA

Senior insider sale

CEO and Chairman at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction

$12.38M

770.59K shares

What this filing means

ROBINS CHAD M plans to sell 770.59K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $12.38M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

InsiderROBINS CHAD MCIK 1780649
DirectorOfficer· CEO and Chairman
Since Jun 2019
770.59K
Shares to sell
$12.38M
Approx. market value
37.26K
Acquired (3 months)
1
Planned
14 completed
Securities Acquired — Last 3 Months1
Sort

Founder's Shares

None

9/1/2009
37.26K
Total acquired37.26K
Planned & Completed Dispositions15
Sort

Completed

Completed

Units to sell

41.67K

Market value

$597.5K

4/6/2026
Completed

Units to sell

41.67K

Market value

$603.3K

4/6/2026
Completed

Units to sell

4.45K

Market value

$71.7K

3/3/2026
Completed

Units to sell

48.63K

Market value

$752.3K

3/3/2026
Completed

Units to sell

41.67K

Market value

$656.0K

3/2/2026
Completed

Units to sell

67.70K

Market value

$1.06M

3/2/2026
Completed

Units to sell

96.32K

Market value

$1.55M

3/2/2026
Completed

Units to sell

41.67K

Market value

$661.0K

3/2/2026
Completed

Units to sell

41.67K

Market value

$653.6K

3/2/2026
Completed

Units to sell

83.67K

Market value

$1.33M

2/27/2026
Completed

Units to sell

99.22K

Market value

$1.59M

2/27/2026
Completed

Units to sell

41.67K

Market value

$763.0K

2/2/2026
Completed

Units to sell

41.67K

Market value

$767.8K

2/2/2026
Completed

Units to sell

41.67K

Market value

$774.2K

2/2/2026

Planned — Approximate Date

NASDPlanned

Units to sell

37.26K

Market value

$553.0K

4/8/2026
Total

Units

770.59K

Value

$12.38M

ROBINS CHAD M — Planned Insider Sale (Form 144) | Finecho